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Primary mitral regurgitation (MR) is the first cause of valvular regurgitation in Western countries. Echocardiography is the cornerstone for
diagnosing MR and more specifically for establishing its aetiology and mechanism, for quantifying its severity, progression, and repercussion
and for assessing the likelihood of successful of valve repair. Two-dimensional/three-dimensional transthoracic and transoesophageal echo-
cardiography are the most widely used methods. Interest is growing for exercise echocardiography particularly in patients in whom symp-
toms do not correlate well with MR severity and for risk stratification. The experience of multi-slice computed tomography in primary MR
is still limited. Conversely, cardiovascular magnetic resonance has gained progressive relevance and represents the alternative method
of choice.
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Introduction
Mitral regurgitation (MR) is the second most frequent valve disease
in Europe after aortic valve stenosis. Since the decline in the inci-
dence of rheumatic valve disease over the past decades, its origin is
predominantly degenerative (61%), followed by rheumatic (14%),
and ischaemic disease (7%).1 The ESC guidelines advocate
surgery in severe primary MR when symptoms, left ventricular
(LV) dysfunction, atrial fibrillation or pulmonary hypertension
(PHT) at rest occur.2 Whether asymptomatic patients with
severe MR should be operated before LV dysfunction or PHT is
established remains the subject of debate. The progress of
primary MR is in general insidious due to progressive atrial and
ventricular remodelling which compensates for the overload
caused by the increased regurgitant volume (RVol). The subse-
quent late onset of symptoms might lead to late referral for
surgery and the outcome of medically treated asymptomatic
severe primary MR remains unclear. Enriquez-Sarano et al.3
found a 5-year probability of 62+8% for cardiac-related death,
heart failure, or new atrial fibrillation in asymptomatic patients
with severe MR while more recently Kang et al.4 reported a
7-year survival free of cardiac death or heart failure of 85+ 4%
in asymptomatic MR with a preserved LV ejection fraction. Con-
versely, Rosenhek et al.5 showed an excellent outcome in asymp-
tomatic severe MR with the ‘watchful waiting’ strategy in
accordance with the ESC guidelines. Recently, numerous studies
have provided evidence for the prognostic value of left atrial en-
largement,6,7 exercise capacity,8,9 and exercise PHT.10 This under-
lines the importance of an adequate assessment of the severity and
consequences of primary MR. Moreover, accurate valve analysis for
predicting repairability is mandatory since it is well established that
mitral valve repair yields a better prognosis than mitral valve re-
placement.11 Transthoracic (TTE) and transoesophageal (TOE)
echocardiography are the classic tools used for evaluating
primary MR.2 Real-time three-dimensional (3D) echocardiography
has moved over the past few years from the research arena to
general clinical practice in many centres. In experienced hands,
3D echocardiography has become the method of choice for evalu-
ating mitral valve. Evidence has also grown for implementation of
stress echocardiography in the imaging armamentarium for asses-
sing asymptomatic patients.12 Although new imaging modalities
such as multi-slice computed tomography (CT) and cardiac mag-
netic resonance (CMR) might provide supplementary findings in
selected cases, their use is still limited in clinical practice. In this
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Figure 1 Two-dimensional transthoracic echocardiography images acquired in a 56-year-old male patient with an isolated P2 prolapse and
severe mitral regurgitation. (A) The parasternal long-axis view shows a prolapse of P2 with a ruptured chordae (arrow). (B and C ) The four-
chamber and two-chamber views do not provide evidence for other prolapsing segments.
Figure 2 (A) Two-dimensional transthoracic echocardiography images. Example of a 71-year-old male patient with a P2 prolapse and a
voluminous calcification (arrow) attaining the posterior part of the mitral annulus and the posterior mitral leaflet. (B) Example of a
66-year-old male patient with Barlow’s disease and a calcification (arrow) at the insertion of the chordae into the anterolateral papillary muscle.
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review, we will examine the cutting-edge knowledge related to the
role of non-invasive multi-imaging modalities in patients with
primary MR.
Transthoracic echocardiography
The European Association of Echocardiography (EAE) recom-
mends TTE as the first-line examination for primary MR.13 A com-
plete exam includes careful valve analysis, hereby describing the
aetiology, the mechanism and the likelihood of valve repair, as
well as the assessment of MR severity.
Mitral valve analysis
The different components of the mitral valve apparatus have to be
evaluated in order to understand the mechanism of MR and
predict the repairability13:
† Leaflets: both anterior and posterior leaflets are classically
divided into three scallops, respectively, referred to as
A1-A2-A3 and P1-P2-P3. The leaflets come together at the
commissures. All these elements can be seen in the parasternal
short-axis view. The parasternal long-axis view usually shows
A2-P2. The apical four-chamber view depicts A3-A2-P1 and
the apical two-chamber view A1-A2-P3. Any anatomical lesion
or prolapsing segment should be described (Figure 1).
† Annulus: the presence and extent of calcification should be
reported (Figure 2). Dilatation of the mitral annulus is defined
as the ratio of annulus/anterior leaflet .1.3 or when the
mitral annulus diameter is .35 mm (parasternal long-axis view).
† Chordae tendinae: classified as marginal (primary), intermediate
(secondary), basal (tertiary), and strut chordae. The presence of
ruptured chordae, calcification, fusion, or redundancy should be
noted.
† Papillary muscles: the posteromedial and the anterolateral pap-
illary muscles adhere, respectively, to the chordae of the medial
half and lateral half of both leaflets. The former is usually
inserted at the inferior wall and the latter at the lateral and pos-
terior wall, although this distribution can vary significantly. Any
rupture, fibrotic elongation, or displacement should be
described.
Aetiology and mechanism
MR is generally classified as primary (organic) or secondary (func-
tional) MR. Primary MR is caused by intrinsic valve lesions as in
endocarditis, degenerative, or rheumatic disease, whereas second-
ary MR results from regional and/or global LV remodelling without
structural abnormalities of the mitral valve (as in cardiomyopathy
or in ischaemic heart disease).
The mechanism is classified according to Carpentier’s functional
classification. In type I, leaflet mobility is normal and MR is the
result of mitral annular dilatation or leaflet perforation. In type II,
Figure 3 (A–B ) Assessment of the severity of mitral regurgitation at rest (A) and during exercise (B) in a 66-year-old male patient with
Barlow’s disease. During test, the severity of MR increased significantly. VC, vena contracta; EROA, effective regurgitant orifice area.
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MR is due to excessive motion of one or both leaflets as in pro-
lapse or flail leaflet. In type III, MR is caused by restriction of
leaflet mobility during diastole and systole (type IIIa, rheumatic
MR) or only during systole (type IIIb, functional MR).
Repairability
The likelihood of mitral valve repair in degenerative MR is excellent
in patients with a P2 prolapse, but is importantly reduced in case of
extensive disease (≥3 scallops affected), anterior commissural
prolapse, severe mitral annulus dilatation (.50 mm), extensive
mitral valve calcification (annulus + leaflets), and large central
regurgitant jet. Mitral valve repair in other forms of primary MR
(rheumatic, endocarditis, . . . ) is unlikely.13
Assessment of mitral regurgitation
severity
MR can easily be diagnosed with colour flow imaging, but this tech-
nique should not be used for grading MR severity. When feasible,
measurement of the vena contracta width and the flow conver-
gence method is recommended if more than a small central jet
is observed.13 The vena contracta is the narrowest portion of
the MR jet and reflects the regurgitant orifice area. The vena
Figure 4 Example of calculation of the global longitudinal strain in two patients with Barlow’s disease, severe mitral regurgitation and normal
left ventricular ejection fraction (.60%). (A) preserved global longitudinal strain (19.8%); (B) altered global longitudinal strain (16%).
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contracta is best imaged in the parasternal long-axis view or in the
apical four-chamber view with an adapted Nyquist limit (colour
Doppler scale) of 40–70 m/s. A vena contracta width ,3 mm is
considered as mild MR, whereas a width ≥7 mm indicates
severe MR. Intermediate values require confirmation by another
approach as with the flow proximal isovelocity surface area
(PISA) method (Figure 3A).
The PISA is best imaged in the apical four-chamber view (or the
parasternal views in anterior mitral valve prolapse) with a reduced
Nyquist limit (15–40 m/s) to obtain a hemispheric isovelocity area.
The PISA radius is measured at mid-systole using the first aliasing.
The use of continuous wave Doppler of the MR jet allows calcula-
tion of the effective regurgitant orifice area (EROA) and the RVol.
Mild primary MR is defined as an EROA ,20 mm2 or a RVol
,30 mL. Severe primary MR is defined as an EROA ≥40 mm2
or a RVol ≥60 mL. Intermediate values define moderate MR
(Figure 3A).
If the PISA method is not feasible, the more time-consuming
Doppler volumetric method can alternatively be used in experi-
enced hands to quantify MR. Additional indicators in favour of
Figure 5 Assessment of the severity of mitral regurgitation by the proximal isovelocity surface area method during two-dimensional trans-
oesophageal echocardiography. Stepwise analysis: (A) two-dimensional images at 758 in a patient with primary mitral regurgitation. (B) The echo
beam focuses on the origin of the mitral regurgitation jet. Contrary to transthoracic echocardiography, the Nyquist limit is augmented in trans-
oesophageal echocardiography until a hemispheric proximal isovelocity surface area is obtained and the proximal isovelocity surface area radius
is measured at mid systole (arrow). (C) After tracing the time-velocity integral of the MR jet acquired by continuous wave Doppler, the effective
regurgitant orifice area is automatically calculated. R Vol, regurgitant volume.
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severe MR are systolic pulmonary flow reversal (depicted by
pulsed wave Doppler of the pulmonary veins), a peak mitral E vel-
ocity .1.5 m/s in the absence of mitral stenosis, a pulsed wave
Doppler mitral to aortic velocity time integral ratio .1.4 and a
dense continuous wave Doppler signal of the MR jet.
From a clinical standpoint, the echocardiographic assessment of
MR includes integration of data from two-dimensional (2D)/3D
imaging of the valve and ventricle as well as Doppler measures
of regurgitation severity.13
Downstream and upstream repercussions
of mitral regurgitation
MR is associated with several haemodynamic changes, which can
alter the clinical outcome. The assessment of LV function, left
atrial dimensions, and pulmonary artery systolic pressure (PASP)
is warranted. The 2007 ESC guidelines advocate surgery when
the LV ejection fraction is ≤60% or the LV end-systolic diameter
reaches ≥45 mm2. However, the LV ejection fraction only
decreases in an advanced state since it first increases in maintain
the forward stroke volume. The LV end-systolic diameter is less
load dependent than the LV ejection fraction, making it a more
appropriate parameter to assess LV dysfunction. Recently, a large
multicentre study provided evidence that elective surgery is a rea-
sonable option in patients with a flail leaflet and a LV end-systolic
diameter .40 mm,14 a value already adopted by the 2008 ACC/
AHA guidelines.15 Moreover, this study confirms previous data16
that post-operative outcome is better if patients are operated
before LV dysfunction is established. These findings imply the ne-
cessity to assess LV function by more sensitive means. Reduced
systolic tissue Doppler velocity at the mitral lateral annulus might
predict post-operative LV dysfunction in patients with asymptom-
atic primary MR and preserved LV ejection fraction and normal LV
end-systolic diameter.17 Furthermore, tissue Doppler imaging can
be used to derive LV strain and strain rate, parameters that
appear more accurate to identify subclinical LV dysfunction.18
Nevertheless, a disadvantage of tissue Doppler imaging is its
angle dependency. Longitudinal strain and strain rate obtained by
2D-speckle tracking imaging, a technique which is not angle de-
pendent, seem to be more sensitive parameters to identify subclin-
ical LV dysfunction in primary MR19 (Figure 4). A global longitudinal
strain ,18.1% has been shown to be associated with post-
operative LV dysfunction in patients with normal pre-operative
LV ejection fraction.20 Another application of speckle tracking is
the relative easy acquisition of torsional parameters, e.g. twist
and torsion (¼twist/LV long-axis dimension), which may represent
useful markers of ventricular function.21 Two recent studies
showed progressive deterioration of the torsion profile in
primary MR,22,23 making these parameters promising indicators
of subclinical LV dysfunction. Practically, the incremental value of
tissue Doppler and strain imaging for identifying latent LV dysfunc-
tion remains to be determined.
Several studies have showed that left atrial enlargement in
primary MR is independently associated with overall and cardiac
Figure 6 Two-dimensional and three-dimensional transthoracic echocardiography images of the mitral valve in a 46-year-old male patient
with a complex Barlow’s disease (bivalvular prolapse). (A) parasternal long-axis, (B) apical four-chamber, (C) apical two-chamber, (D) The three-
dimensional ‘en face’ view from the left atrium shows more clearly the prolapsing segments (anterior leaflet prolapse + P2–P3 and A3–P3
commissure prolapse.
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mortality6,7 (diameter .40–50 mm or LA volume index .60 mL/
m2). In addition, data showed that left atrial remodelling precedes
and exceeds LV remodelling24 and that mitral valve surgery in
patients with left atrial enlargement restores life expectancy.7
These are strong arguments to take this parameter into account
for deciding whether or not an asymptomatic patient with
severe MR and normal LV ejection fraction should be operated.
The indexed left atrial volume has been shown to correlate
better with indirect indices of LV filling pressure than the antero-
posterior left atrial diameter,25 and is thus the preferred parameter
to assess left atrial enlargement.
Finally, the PASP is classically obtained by summing the transtri-
cuspid pressure gradient and the estimated right atrial pressure.
A value .50 mmHg is a Class IIa indication for mitral valve
surgery.2 Recent data have shown that PHT is a predictor of
worse outcome after mitral valve surgery,26 favouring early
surgery before PHT is established.
Transoesophageal
echocardiography
TOE is recommended in the operating room just before mitral
valve surgery and in case of insufficient transthoracic imaging
quality.13 Usually TOE is also performed for further diagnostic re-
finement in the pre-operative setting, although TTE is highly accur-
ate in experienced hands to predict valve reparability since the
introduction of harmonic imaging technology.
According to the 2010 EAE recommendations for TOE, essen-
tial views for accurate valve analysis are the following:27
† Transgastric basal short-axis view at 08: allows the visualiza-
tion of the six scallops and the two commissures. The use
of colour Doppler in this view may also indicate the localiza-
tion of the origin of the regurgitant jet and thus of the
prolapse.
† Multiple lower transoesophageal views: for complete appreci-
ation of all scallops, rotation of the image through 1808 as
well as systematic analysis of parallel planes can be performed.
Papillary muscle and chordae integrity have to be evaluated.
Any vegetation should be excluded.
† Colour Doppler assessment of the regurgitant jet: the severity
of MR is graded by the same criteria as in TTE13 (Figure 5).
† Pulsed wave Doppler of the left upper pulmonary vein (right
upper pulmonary vein in case of eccentric jet): systolic flow
reversal is suggestive for severe MR.
Systolic blood pressure should be recorded during any echocar-
diographic grading of the severity of MR, since it can be underes-
timated in conditions of low pre and afterload.27
Three-dimensional
echocardiography
Although 2D echocardiography remains the primary tool for the
assessment of MR, it is reasonable to perform a 3D TTE/TOE in
Figure 7 Planimetry of the anatomic regurgitant orifice area by three-dimensional transthoracic echocardiography.
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complex mitral valve pathology.13 Three-dimensional echocardiog-
raphy represents a valuable method for valve analysis when avail-
able since several studies have demonstrated its superiority over
2D TTE/TOE for accurate localization of the valve lesion28,29
(Figure 6). To note, the majority of them has used 3D TOE.
Despite its lower spatial resolution, 3D imaging has several advan-
tages over 2D imaging in the pre- and intra-operative settings. It is
particularly useful in the dialogue between the echocardiographer
Figure 8 Three-dimensional assessment of left ventricular volumes, ejection fraction, and longitudinal myocardial deformation (speckle track-
ing) obtained with 3D transthoracic echocardiography.
Figure 9 Cardiac multi-slice computed tomography obtained in patients with mitral valve pathology allowing direct visualization of the mitral
valve leaflets and the subvalvular apparatus (by courtesy of R.Salgado, University Hospital of Antwerp). (A) Four-chamber view showing a pro-
lapse of the thickened anterior leaflet (arrow). (B) Four-chamber view in a patient with rheumatic valve disease characterized by the
hockey-stick sign of the posterior leaflet (arrow).
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and the surgeon. Simultaneous multi-plane imaging permits to pre-
cisely determine the localization and the extent of lesions. Colour
flow Doppler imaging can be superimposed onto these 2D images,
which may make easier the identification of commissural jets. With
the use of real-time 3D imaging, the mitral valve is best imaged
when obtained in zoom mode to avoid stitch artefacts that may
occur in a wide-angled acquisition. With both TEE and TOE, the
unique ‘en face’ view, which is similar to the surgical view after
left atriotomy, can be displayed. To simulate the surgeon’s view
of the valve, the 3D image is reoriented to exhibit the aortic
valve at the 11 o’clock position. The subvalvular apparatus is on
the opposite best imaged from the LV perspective. To note, the
gated full volume modality (wide-angled acquisition of four ECG-
gated pyramidal volumes) is the ideal way for imaging the entire
mitral valve apparatus (chordae, papillary muscle, LV). Recently,
new-dedicated software for advanced 3D analysis of the mitral
valve has been developed to be incorporated into clinical practice.
It provides a 3D realistic model of the mitral valve and allows the
calculation of a range of parameters (annulus, anterior and poster-
ior leaflet, leaflet segmentation, coaptation line and potential coap-
tation defects, mitral valve spatial relationship with the papillary
muscles and aortic valve). The possibility to measure the surface
of the anterior leaflet to estimate, in a beating heart, the size of
the annular ring ranks among the most interesting features. The
added value of these parameters still needs to be defined.
Several studies using 3D TOE for planimetry of the anatomical
regurgitant orifice have found a high correlation with the 2D
vena contracta and the PISA method.30,31 A recent study
showed its superiority over the PISA method in eccentric jets.31
This technique was feasible in all patients; however, it remains
time consuming and may be challenging in very calcified, perfo-
rated, or flail leaflets.
The use of 3D colour flow volumetric imaging allows direct as-
sessment of the size and shape of the regurgitant orifice, prevent-
ing the geometric assumptions applied by 2D imaging.32 With
manual cropping of the image plane perpendicularly orientated
to the jet direction, the narrowest cross-sectional area of the
MR jet can be obtained in an ‘en face’ view and measured by plan-
imetry in systole (Figure 7). In primary MR, the shape of the regur-
gitant orifice has been shown to be relatively rounder.
Three-dimensional colour Doppler imaging for assessing MR
severity is, however, not yet daily practice. No method has
proved to have a good correlation with reference imaging modal-
ities in large series of patients with varying degrees of MR severity.
To note, new 3D/4D ultrasound probe generations will allow auto-
matic visualization of 3D PISA surface and anatomic orifice area,
with expected higher accuracy of the subsequent RVol calculation.
Moreover, over the past decade, 3D echocardiography has
proved to be more accurate and reproducible than 2D echocardi-
ography regarding measurement of LV volumes and LV ejection
fraction when compared with independent reference imaging mo-
dalities (radionuclide ventriculography, CMR). Unlike the 3D tech-
nique, 2D echocardiography consistently underestimates LV
volumes due to foreshortened views and geometrical assumptions.
Consequently, 3D echocardiography should be routinely used to
assess LV volumes and LV ejection fraction when available.
Three-dimensional speckle tracking echocardiography is a new
promising method to evaluate regional LV function,33 but its super-
iority over standard 2D TTE for the assessment of the LV function
has still to be proved (Figure 8).
To conclude, 3D echocardiography might provide useful
information complementary to the standard 2D
echocardiography.
Exercise tests and exercise
echocardiography
Recent studies showed that decreased exercise capacity in asymp-
tomatic patients with primary MR, revealed by a reduced peak
oxygen consumption during cardiopulmonary exercise testing9 or
a decreased duration at exercise tolerance test,8 is predictive for
cardiac events and mortality. Probably these exercise tests
unmask ‘asymptomatic’ patients who adapted and reduced their
daily activities to avoid symptoms.34 Subsequently, reduced exer-
cise capacity might be considered as an indication for surgery in
severe primary MR. The 2008 EAE guidelines for stress echocardi-
ography recommend exercise echocardiography when symptoms
are discordant with MR severity at rest.35 In fact, primary MR
can have a dynamic character in up to one-third of patients36
(Figure 3). Exertional dyspnoea in patients with moderate MR at
rest might be explained by the development of severe MR with
Figure 10 Contrast-enhanced coronary computed angiography. Visualization of normal coronaries in a low-risk patients with mitral valve
prolapse. LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; RCA, right coronary artery.
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PHT during exercise.37 Interestingly, two recent studies showed
that either an increased PASP or an increase in EROA was asso-
ciated with a decreased symptom-free survival.10,36 Moreover,
the absence of contractile reserve—weaker changes in the
LV ejection fraction (.4%) or in global longitudinal strain
(,2%)—revealed by stress echocardiography identifies patients
with subclinical LV dysfunction. These patients are at risk for post-
operative LV deterioration and morbidity.20,38 Consequently, the
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2010 EAE recommendations for the assessment of valvular regur-
gitation13 support the use of exercise echocardiography to identify
high-risk patients who may benefit from early elective surgery. To
note, according to the ACC/AHA 2008 Guidelines, exercise
Doppler echocardiography is reasonable (class IIa, level of evi-
dence C) in asymptomatic patients with severe MR to assess the
effect of exercise on MR severity and on pulmonary artery pres-
sure (significant if .60 mmHg).15 However, exercise PHT in
older patients should be interpreted cautiously since one-third of
normal subjects older than 60 years may present a PASP
.60 mmHg at peak exercise.39 However, exercise PHT during a
low level of exercise should be regarded as a pathological
finding. Practically, instead of straightforward risk stratification, ex-
ercise echocardiography may thus be helpful for guiding the
optimal timing of intervention, especially in patients in whom the
risk to benefit ratio of surgery is uncertain (doubt about reparabil-
ity, comorbidity, advanced age).
Multi-slice cardiac computed
tomography
Multi-slice cardiac CT, from thin-section reconstructions, allows
direct visualization of the thickening and calcification of the leaflets,
mitral annulus, chordae, and papillary muscles (Figure 9). A recent
study showed good correlation with 3D TOE concerning measure-
ments of mitral valve geometry and leaflet lengths and angles.40
The extent of calcification of the mitral annulus might even be
better demonstrated than by echo or CMR.41
The inner contour of the regurgitant orifice can manually be
outlined on reconstructed cross-sectional images of the mitral
valve in oblique short axis. Two studies have demonstrated that
cardiac CT-derived anatomical regurgitant orifice area correlates
well with EROA measured by echocardiography.42,43
Chamber dimensions can be obtained after post-processing of
the images with a contour-detection algorithm and manual
Figure 11 Multi-imaging modality in a patient with posterior mitral leaflet prolapse, preserved left ventricular function and severe mitral re-
gurgitation. (1A–C) Two-dimensional and three-dimensional transthoracic echocardiography showing a P2 prolapse. (1B–C) Three-dimensional
volume rendering of the mitral valve. (1C) ‘en face view’ of the mitral valve. (1D) P2 prolapse demonstrated by cardiovascular magnetic res-
onance. (1E) Surgical view of the P2 prolapse. (2A–D) Two-dimensional and three-dimensional transoesophageal echocardiography confirming
the isolated P2 prolapse. (2D) Three-dimensional rendering of the mitral valve allowing the measurement of the surface of the anterior leaflet.
(3) Quantification of the mitral regurgitation using the proximal isovelocity surface area method. (A) Apical four-chamber view with colour flow
display, (B) zoom of the selected zone + downward shift of zero baseline to obtain an hemispheric proximal isovelocity surface area. (C) con-
tinuous wave Doppler of mitral regurgitation jet allowing calculation the effective regurgitant orifice area and regurgitant volume. TVI, time-
velocity integral. (4A–B) Quantification of mitral regurgitation using cardiac magnetic resonance. (A) Total stroke volume derived from left ven-
tricular volumes assessment. (B) Forward stroke volume derived from velocity-encoded cardiac magnetic resonance flow quantification of
aortic flow. (5) Planimetry of the anatomical regurgitant orifice area on a slice parallel to the valvular plane obtained by cardiac magnetic res-
onance. (6) Detection of cardiac fibrosis by cardiac magnetic resonance. This delayed contrast enhancement cardiac magnetic resonance image
shows an important zone of fibrosis in the free wall of the left ventricle (arrow) (by courtesy of L. Davin, CHU de Lie`ge). Coronary artery
disease was excluded by coronary angiography.
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correction if not satisfactory. The RVol can be generated as the dif-
ference between the calculated stroke volume of the left and the
right ventricle and has recently be shown to have a good correl-
ation with the RVol obtained by CMR.44
Although multi-slice cardiac CT might be particularly useful in
the pre-operative setting by providing complementary informa-
tion on the coronary arteries (high negative predictive value in
patients who are at low risk of atherosclerosis), a routine clinical
implementation is not yet recommended (Figure 10). Radiation
exposure and the use of nephrotoxic contrast are the main
concerns of this imaging modality at present. Furthermore, this
technique is not suitable in patients with arrhythmia because of
the ECG-gated acquisition. However, cardiac CT might be an
alternative for patients with poor echogenicity when CMR is
contra-indicated (pacemaker).
Cardiac magnetic resonance
Practically, in patients with primary MR, CMR should be considered
as the first choice alternative, when echocardiography is not conclu-
sive. Indeed, CMR is the most accurate and reproducible non-
invasive method for the assessment of LV volumes, LV ejection frac-
tion, and torsional parameters.45 Basically, the LV dimensions are
derived from a series of multi-section perpendicular to the long
axis of the LV (10–12 contiguous slices in the short-axis direction).
CMR can also be used for valve analysis using ‘steady-state free
precession (SSFP)’ sequences, which precisely discriminate blood
from tissue.46 First, mitral valve function can be assessed with
cine imaging. Turbulent flow through MR orifice is easily visible
with SSFP (visualization of signal voids due to spin dephasing in
moving protons).
Mitral valve anatomy can be imaged by acquisition of standard
short-axis, two-, three-, and four-chamber long-axis views in com-
bination with oblique long-axis cines orthogonal to the line of co-
aptation as described by Chan et al.47 CMR has comparable
diagnostic value to echocardiography for the identification of pro-
lapsing scallops,48,49 but is inferior for imaging the subvalvular ap-
paratus (torn chordae) due to lower spatial and temporal
resolution48 (Figure 10A and B).
One study has used SSFP CMR for assessing the EROA by plan-
imetry of the regurgitant orifice in a slice parallel to the valvular
plane and perpendicular to the regurgitant jet at mid-systole.
Quantification of EROA was correlated well with angiographic
and echocardiographic data50 (Figure 11). To note, CMR planim-
etry defines the anatomic regurgitant lesion, whereas the areas
of EROA by PISA yield the narrowest flow stream, which tends
to be smaller than the anatomic orifice area. It should also be
underlined that the regurgitant orifice is frequently inconstant
throughout systole in primary MR. This can potentially affect the
estimation of the regurgitant severity. Lastly, planimetry of the
MR regurgitant orifice is time consuming and remains challenging
because appropriate plane alignment and angulation may be
more difficult due to the longitudinal movement of the mitral
annulus and in case of irregular shapes of regurgitant orifice.
Furthermore, with CMR, blood flow and velocity can be accurate-
ly obtained by phase-contrast velocity mapping. Hence, RVol can be
measured indirectly as the difference between the total stroke
volume and the aortic flow (forward stroke volume), as well as dir-
ectly as the regurgitant flow across the mitral valve.46 This latter,
however, requires a specialized imaging sequence which tracks the
motion of the mitral valve annulus during the cardiac cycle. In the
absence of other regurgitant lesions, a rare situation in primary
MR, R Vol can also be calculated by substracting the right ventricle
stroke volume from the LV stroke volume. However, the calculation
of the right ventricle stroke volume is less reproducible due to the
extensive trabeculation of the right ventricle.
Late gadolinium enhancement CMR (images obtained 10–20 min
after injection of contrast) is widely used to assess cardiac fibrosis in
various cardiomyopathies. In contrast, there are practically no
studies having investigated cardiac fibrosis by CMR in primary MR
(Figure 11). Perivalvular ventricular fibrosis and papillary muscle fi-
brosis have been well described in pathological studies, but not in
vivo. Recently, Han et al.49 using 3D high-resolution late gadolinium
enhancement CMR imaging have shown for the first time the pres-
ence of focal myocardial fibrosis in the papillary muscles in several
patients with mitral valve prolapse. Such hyperenhancement of pap-
illary muscles was more often associated with the presence of
complex ventricular arrhythmias. In addition, the blood-to-leaflet
contrast ratio was also increased in these patients, which may
reflect the significantly expanded spongia layer with proteoglycans
in the myxomatous valve.
In practice, the routine use of CMR is limited because of more
difficult access to CMR than to echocardiography, and the need for
specific expertise of radiologists and/or cardiologists in imaging.
Other disadvantages of CMR are related to its potential incompati-
bility with pacemakers and the ECG-gated acquisition, which pro-
vokes problems in patients with arrhythmia. Lastly, limitations may
come from the technique itself as the low spatial resolution of 2D
CMR compared with 3D high-resolution late gadolinium enhance-
ment CMR imaging.
Conclusion
TTE and TOE remain the first-line imaging modalities for the as-
sessment of primary MR. Recent techniques as tissue Doppler
imaging and speckle tracking echocardiography appear to be prom-
ising tools in detecting subclinical LV dysfunction. If available, 3D
echocardiography may provide superior evaluation of LV function
and valve analysis in experienced centres. Exercise echocardiog-
raphy is an excellent tool for the assessment of the functional
repercussions of primary MR and for the identification of high-risk
patients who might benefit from early elective surgery. In patients
with poor echogenicity, CMR is the alternative imaging modality of
choice for evaluating MR. Routine assessment with cardiac CT is
not yet recommended, but its role might increase as radiation
and contrast doses further regress in the future.
Conflict of interest: none declared.
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